Search for: "v. Teva Pharmaceuticals USA, Inc." Results 301 - 320 of 440
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Sep 2010, 12:02 pm by The Docket Navigator
Teva Pharmaceuticals USA Inc. et al., 1-08-cv-00464 (DED September 21, 2010 Memorandum) (Bartle, J.) [read post]
2 Feb 2018, 1:31 pm by Gregory Sephton
Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries, Ltd., Case 2016-1284, 2016-1787 (Fed. [read post]
27 Nov 2018, 9:30 am by Ronald Mann
Teva Pharmaceuticals USA Inc. presents the next one of those cases. [read post]
19 Apr 2010, 1:34 pm by FDABlog HPM
District Court for the District of Delaware’s recent decision in Millennium Pharmaceuticals, Inc. v. [read post]
6 Nov 2015, 6:58 am
  Therefore, it was not obvious to test pregabalin – it might be obvious to test gabapentin, but even here the judge considered that the skilled team would have little expectation of success.InsufficiencyAccording to the caselaw relating to sufficiency developed in MedImmune Ltd v Novartis Pharmaceuticals UK Ltd [2011] EWHC 1699 (Pat) at [458]-[484] and summarised in Sandvik Intellectual Property AB v Kennametal UK Ltd [2011] EWHC 3311 (Pat) at… [read post]
25 May 2010, 12:51 pm by FDABlog HPM
The first Petition is docketed as Docket No. 09-993 and was filed by PLIVA, Inc., Teva Pharmaceuticals USA, Inc., and UDL Laboratories, Inc. [read post]
21 Aug 2008, 9:43 pm
  Following the Federal Circuit's decision in Teva Pharmaceuticals USA, Inc. v. [read post]
27 Jun 2011, 8:41 am by Kali Borkoski
” Certiorari stage documents: Opinion below (3d Circuit) Petition for certiorari Brief in opposition Petitioners’ supplemental brief Respondents’ supplemental brief Petitioners’ reply Amicus brief of TEVA Pharmaceuticals USA, Inc. [read post]
2 Sep 2010, 10:51 am by Dennis Crouch
Teva Pharmaceuticals USA, Inc., 566 F.3d 989 (Fed. [read post]